NOV 25, 2021 5:00 AM PST

What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?

WRITTEN BY: Tara Fernandez

All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, vaccines differ in how they deliver the 'training material' and which immune cells they target.

One of the main concerns about the vaccines currently authorized for use (such as the Pfizer/BioNTech and Moderna) is that their immunologic protection could diminish over time. Public health officials say the solution is to administer a vaccine booster dose. 

"Authorizing the use of a single booster dose of either the Moderna or Pfizer-BioNTech COVID-19 vaccine for individuals 18 years of age and older helps to provide continued protection against COVID-19, including the serious consequences that can occur, such as hospitalization and death," said the FDA in an official statement.

However, a newly-developed second-generation vaccine could eliminate the need for boosters by offering sustained, longer-lasting immune protection in those who receive it. This technology, known as a T cell vaccine, is administered as a skin patch. Unlike the current COVID-vaccines, which shield against infection via an antibody response, T cell vaccines activate virus-killing T cells to do the job. As soon as a virus gains entry, T cells rush to the scene and clear them in what scientists are calling "abortive infections."

One of the benefits of the T cell vaccine approach is that it is more resistant to mutational changes in the virus over time. Antibodies work by recognizing specific molecular features on SARS-CoV-2. However, as these features transform due to mutations, antibodies lose sight of their targets, and their activity recedes.

According to Emergex, the drug developer pushing a T cell COVID vaccine towards the clinic, figuring out an optimal delivery mechanism for the vaccine was a challenge. Researchers ended up with a design that uses gold nanoparticles studded with viral proteins that sit on a bed of micro-needles. These are affixed to a small plastic patch applied to the skin's surface, releasing the vaccine's active ingredients in seconds. 

The skin patch has a significant leg up over existing COVID vaccines in terms of how easy it is to distribute widely. The patches are stable at room temperature for up to three months (unlike temperature-sensitive mRNA vaccines that require cold storage).

Interestingly, T cell vaccines have a broad range of potential applications beyond just coronavirus. An ongoing clinical trial is investigating whether T cell vaccines can effectively protect against dengue fever. The drug developer is also looking to use a similar technology to defend against influenza, Zika, and Ebola viruses.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 02, 2021
Microbiology
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
DEC 02, 2021
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
Crimean-Congo hemorrhagic fever (CCHF) is a deadly disease, which is fatal in about 30 percent of cases. It's caused ...
DEC 30, 2021
Cell & Molecular Biology
Researchers Discover Immune Cell Subtype Linked to MS and Neuroinflammation
DEC 30, 2021
Researchers Discover Immune Cell Subtype Linked to MS and Neuroinflammation
We still don't know exactly what causes multiple sclerosis (MS), or many other disorders that involve inflammation in th ...
JAN 04, 2022
Immunology
Scientists Win a Game of Bacterial Hide-And-Seek
JAN 04, 2022
Scientists Win a Game of Bacterial Hide-And-Seek
When infection strikes, antibiotics are the go-to solution to help patients regain control from the invading bacter ...
JAN 06, 2022
Immunology
Worryingly High Levels of Free Radicals in COVID Patients
JAN 06, 2022
Worryingly High Levels of Free Radicals in COVID Patients
  COVID-19 infections trigger widespread oxidative damage, says new research by scientists from the Baylor College ...
JAN 07, 2022
Health & Medicine
Israel Approves Fourth Dose of COVID-19 Vaccine
JAN 07, 2022
Israel Approves Fourth Dose of COVID-19 Vaccine
While third doses are being approved for adults in countries worldwide, Israeli citizens are already receiving a fourth. ...
JAN 13, 2022
Immunology
Gene Unveiled as Missing Link in Antibody Development
JAN 13, 2022
Gene Unveiled as Missing Link in Antibody Development
  Antibodies are a core part of the immune system's pathogen-fighting arsenal, defending the body against bacte ...
Loading Comments...